Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy


Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.

You May Also Like

The bull case for Nvidia just got stronger, according to these Wall Street analysts

“Insatiable” AI demand and revenue opportunities from China are leading analysts to…

Stocks headed to the Moon if Yellen whips out a surprise this month, says Nomura strategist

Investors are a day away from an inflation report that may offer…

‘My wife and I are very grateful’: Our son wants to pay off our mortgage before we retire. Will this backfire?

“He’s also the executor of our will.”

US and Japan warn of China threat as they upgrade military alliance

The US and Japan have outlined the most significant upgrade to their…